SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
1-Year Return
8.73%
This Quarter Return
-0.45%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$1.44B
AUM Growth
-$16M
(-1.1%)
Cap. Flow
+$44.3M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
85.81%
Holding
128
New
21
Increased
19
Reduced
33
Closed
33
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$143M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$88.2M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$10.3M |
| 4 |
DexCom
DXCM
|
$8.2M |
| 5 |
ResMed
RMD
|
$6.89M |
Top Sells
| 1 |
Simplify MBS ETF
MTBA
|
$55.3M |
| 2 |
Schwab US TIPS ETF
SCHP
|
$38.1M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$25M |
| 4 |
Sarepta Therapeutics
SRPT
|
$19.5M |
| 5 |
Zoetis
ZTS
|
$11.7M |
Sector Composition
| 1 | Healthcare | 11.03% |
| 2 | Energy | 1.63% |
| 3 | Industrials | 1.06% |
| 4 | Consumer Discretionary | 0.54% |
| 5 | Real Estate | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Stryker
SYK
$151B
| $434K | 0.02% |
1,206
-606
| -33% | -$218K |
|
77
Jasper Therapeutics
JSPR
$42.6M
| $428K | 0.02% |
+20,000
| New | +$428K |
|
78
CVS Health
CVS
$92.9B
| $409K | 0.02% |
+9,114
| New | +$409K |
|
79
Fulcrum Therapeutics
FULC
$346M
| $379K | 0.02% |
80,714
-270,600
| -77% | -$1.27M |
|
|
CIM
80
Chimera Investment
CIM
$1.17B
| $360K | 0.02% |
25,700
+15,700
| +157% | +$220K |
|
81
TG Therapeutics
TGTX
$4.94B
| $338K | 0.02% |
+11,237
| New | +$338K |
|
82
Danaher
DHR
$139B
| $313K | 0.02% |
1,365
-707
| -34% | -$162K |
|
|
CEE
83
Central and Eastern Europe Fund
CEE
$103M
| $265K | 0.01% |
24,235
| – | – |
|
84
Zimmer Biomet
ZBH
$20.7B
| $244K | 0.01% |
2,307
-1,228
| -35% | -$130K |
|
85
Agilon Health
AGL
$485M
| $210K | 0.01% |
110,520
-58,176
| -34% | -$111K |
|
86
Delcath Systems
DCTH
$380M
| $205K | 0.01% |
+17,000
| New | +$205K |
|
|
QVCGA
87
QVC Group, Inc. Series A Common Stock
QVCGA
$69.4M
| $198K | 0.01% |
12,000
+5,000
| +71% | +$82.5K |
|
|
TWO
88
Two Harbors Investment
TWO
$1.06B
| $130K | 0.01% |
11,000
+1,000
| +10% | +$11.8K |
|
|
CMPS
89
Compass Pathways
CMPS
$460M
| $53.9K | ﹤0.01% |
+14,248
| New | +$53.9K |
|
90
Apple
AAPL
$3.52T
| – | – |
-997
| Closed | -$232K |
|
91
AbbVie
ABBV
$376B
| – | – |
-47,252
| Closed | -$9.33M |
|
92
Advanced Micro Devices
AMD
$260B
| – | – |
-3,586
| Closed | -$588K |
|
93
Amazon
AMZN
$2.48T
| – | – |
-1,185
| Closed | -$221K |
|
94
ASML
ASML
$296B
| – | – |
-250
| Closed | -$208K |
|
95
Avantor
AVTR
$8.78B
| – | – |
-84,678
| Closed | -$2.19M |
|
96
Biogen
BIIB
$20.2B
| – | – |
-2,470
| Closed | -$479K |
|
97
BioMarin Pharmaceuticals
BMRN
$11B
| – | – |
-8,489
| Closed | -$597K |
|
98
CAVA Group
CAVA
$7.62B
| – | – |
0
| – | – |
|
99
Elevance Health
ELV
$69.4B
| – | – |
-8,762
| Closed | -$4.56M |
|
|
EQLS
100
DELISTED
Simplify Market Neutral Equity Long/Short ETF
EQLS
| – | – |
-94,670
| Closed | -$2.05M |
|